Veterinary Alert: Severe Feline Illness Linked to Oclacitinib Ingestion

Orange tabby cat with feeding tube at vet for severe feline illness oclacitinib ingestion.

The Alarming Rise of Oclacitinib Ingestion in Cats

Veterinary professionals are sounding the alarm as incidents of felines falling seriously ill after ingesting oclacitinib chewable tablets are increasing. Recently, NC State College of Veterinary Medicine reported two acute cases where cats developed severe kidney injuries after consuming these tablets originally designed for canine use.

Oclacitinib, an allergy medication meant for dogs, has been found to be enticing to some cats due to its pork liver flavor. Unfortunately, the consequences have been dire. Both cats treated at NC State required hemodialysis following their ingestion of the chewable form of the drug. This has drawn concern from veterinarians that such incidents could lead to fatalities, particularly given past reports of high ingestion levels resulting in death.

Understanding Oclacitinib and Its Risks to Cats

Initially marketed as a treatment for allergic dermatitis in dogs, oclacitinib chewable tablets have gained notoriety for their unintended effects on feline recipients. “The incidence of Apoquel ingestion-related toxicity has increased at our hospital since the release of a chewable formulation,” Dr. Tyler Johnson stated, emphasizing the need for better education among pet owners.

Cats that ingest oclacitinib may suffer a range of severe clinical signs including lethargy, vomiting, diarrhea, and even kidney damage. Such outcomes make it crucial for veterinarians to consider the family pet dynamics—especially in homes with both dogs and cats—before prescribing this medication.

Taking Action: Recommendations for Veterinary Practices

To mitigate risks, Dr. Shelly Vaden suggests that veterinarians inquire about the presence of cats in households before dispensing the chewable version of oclacitinib. This proactive approach could lead to better health outcomes for both dogs and cats. In cases where cats are present, Dr. Vaden advocates for using the non-chewable form of the medication, which is less accessible to curious felines.

Such precautionary measures are becoming increasingly important as the veterinary landscape shifts. An uptick in awareness among practitioners and a clear communication strategy with pet owners could help prevent further cases of toxicity. Ensuring that clients are well-informed regarding the dangers of oclacitinib for cats is essential for the health and safety of pets across households.

Operations

0 Views

0 Comments

Write A Comment

Related Posts All Posts

08.15.2025

Understanding Canine Acanthomatous Ameloblastoma: A Vital Case Study for Veterinary Clinics

Update Darla’s Journey: A Case Study in Veterinary Care In the realm of veterinary medicine, the case of Darla, an 11-year-old Newfoundland/Labrador mix, shines a light on the complexities and decisions surrounding medical care for aging pets. Diagnosed with canine acanthomatous ameloblastoma (CAA), a benign but locally aggressive oral tumor, Darla’s owners faced a heart-wrenching decision regarding her treatment options. Their story reflects the increasing necessity of emotional support and financial aid for pet owners who encounter such challenging situations, which can later translate into meaningful narratives for veterinary clinics to share with potential clients. Tumors in Pets: Understanding CAA Canine acanthomatous ameloblastomas often present as noticeable growths in a pet's mouth, manifesting symptoms such as oral bleeding, loose teeth, and facial swelling. While they are benign, if left untreated, these tumors can cause significant harm to a dog's quality of life. Identifying the signs early is crucial for maintaining a pet's health and alleviating any discomfort they might experience, emphasizing the role of regular veterinary check-ups, which can be an alert point of engagement for clinics. Financial Assistance: A Vital Resource The Gombert family’s experience highlights the importance of financial aid in veterinary care. Thanks to a grant from the Petco Love Foundation in partnership with the Blue Buffalo Foundation, they could afford the necessary surgery for their beloved dog. This aspect of Darla's story points to the need for veterinarians to be aware of, and promote, funding opportunities to their clients. Not only does this support enhance the welfare of pets, but it also keeps clients engaged and loyal to their veterinary practices. Successful Outcomes and Future Implications Following surgery at the UC Davis Veterinary Medical Teaching Hospital, Darla made a successful recovery without complications, preserving much of her mandible. Prognosis post-surgery indicates that with complete removal of CAA, outcomes are generally excellent. This successful case can serve as a powerful narrative for veterinary practices, showcasing potential successes and reassuring clients contemplating similar procedures for their pets. Building Trust with Clients: Lessons to Consider Darla's story serves as a case study in building trust with pet owners through transparent communication about the costs and benefits of treatments. Veterinary clinic owners can foster deeper relationships with clients by sharing success stories, addressing financial concerns empathetically, and providing guidance on available resources. Such initiatives can enhance client loyalty, reducing turnover and increasing clinic profitability. In conclusion, veterinarians should continue to engage in discussions around treatment options and financial aids available to owners. By developing patient-centered approaches and sharing success stories like Darla’s, veterinary clinics can enhance their operations and build lasting connections with their clients.

08.15.2025

Draeger Breathing System Filters Recalled: Critical Safety Alerts for Veterinary Clinics

Update Serious Recall for Breathing System Filters: What Veterinary Clinics Need to Know In a critical announcement, the FDA has initiated a recall of specific bidirectional breathing system filters—SafeStar and TwinStar—produced by Draeger, due to significant safety risks linked to misleading capnography readings. This decision is particularly relevant for veterinary clinics, as these filters are commonly employed during anesthesia and mechanical ventilation for both animals and humans. Failure to address this recall could lead to dangerous consequences, including potential injury or even death among patients. Understanding the Risk The primary concern with the recalled filters is their ability to produce inaccurate carbon dioxide (CO2) readings. The FDA highlighted that misleading waveform interpretations could lead to unnecessary or harmful treatments, resulting in serious injuries to the airway or brain. While no fatalities have been reported, the potential for significant harm warrants immediate action. What Veterinary Clinics Should Do Veterinary clinic owners and managers must act swiftly upon hearing this news. Draeger recommends that clinics cease using the affected filters and remove any unused stock from their inventory. Additionally, affected clinics should: Contact Draeger Consumables for information on alternative filters. Reach out to Draeger Customer Success at 1-800-437-2437 to arrange for product returns and replacements. Inform all potential users about the recall and ensure communication is forwarded to any third-party users. Complete the updated Recall Return Response Acknowledgment and Receipt Form. Preparing for Future Safety In light of this recall, it’s paramount for veterinary clinics to review their protocols for monitoring and managing equipment used during procedures. This recall serves as a reminder of the critical importance of maintaining safety standards and ensuring that all medical devices are functioning correctly. Considerations for future purchases should include thorough investigation of supplier histories and transparency about device risks. For any questions or concerns regarding the recall, or to report any issues, clinics should contact Draeger’s customer support to ensure proactive measures are taken to protect both staff and patients alike. Stay informed and proactive, your clinic's commitment to patient safety depends on it!

08.15.2025

Caution Urged for Cat Owners: Risks of Oclacitinib Chewables

Update Rising Concern Among Veterinary Professionals In recent times, the NC State College of Veterinary Medicine has sounded alarms following a rise in severe health issues among cats caused by the ingestion of oclacitinib chewable tablets, known commercially as Apoquel, prescribed primarily for dogs. With two cats recently requiring multiple rounds of hemodialysis after consuming these dog-specific allergy medications, the message is clear: vigilance is essential in mixed-pet households. The Impact of Crossover Medications Oclacitinib is utilized in dogs for managing itching related to allergic reactions and dermatitis. However, there’s a pressing concern that arises when cats mistakenly ingest this canine medication, putting them at significant health risks, including acute kidney injury, lethargy, vomiting, and even severe liver damage. As veterinary expert Tyler Johnson, DVM, pointed out, the recent increase in these cases correlates with the chewable format's introduction, which cats find enticing, leading to accidental ingestions. Guidance for Veterinary Practices Veterinarians, particularly those serving families with both cats and dogs, are urged to exercise heightened caution. Shelly Vaden, DVM, recommends assessing the presence of cats in a household prior to prescribing Apoquel in its chewable form. Without proper precautions, such as opting for the non-chewable version or explicit advisories to pet owners regarding storage and administration, the ramifications could be grave, including potential fatalities. Taking Preventative Steps to Protect Cats Preventative measures must become a primary focus in veterinary settings. Educating clients about the serious risks associated with the misuse of medications intended solely for dogs is crucial. Veterinary teams should also ensure that any medications dispensed are accompanied by clear instructions about safe storage away from the reach of cats. Such initiatives not only safeguard the felines but also enhance trust and reliability between pet owners and veterinary practices. Community Awareness is Key As the veterinary community confronts this emerging crisis, awareness is paramount. Engaging with pet owners through informative sessions and detailed literature can strengthen household safety. By creating a culture of care and caution, veterinarians can help mitigate this risk, ensuring the well-being of all pets in their care.

Veterinary Alert: Severe Feline Illness Linked to Oclacitinib Ingestion

The Alarming Rise of Oclacitinib Ingestion in Cats

Understanding Oclacitinib and Its Risks to Cats

Taking Action: Recommendations for Veterinary Practices

Terms of Service

Privacy Policy

Core Modal Title